910330-24-4

Upstream product

• 3433-80-5 1-Bromo-2-bromomethyl-benzene 
• 71813-50-8 1-bromo-2-(but-3-enyl)benzene 
• 92013-30-4 4-(o-bromophenyl)butyryl chloride 
• 90841-47-7 4-(2-bromophenyl)butanoic acid 
• 123206-83-7 4-(2-Bromophenyl)-1-butanol 
• 68449-30-9 5-bromo-1-tetralone 
• 1423-26-3 (meta-(trifluoromethyl)phenyl)boronic acid 

Downstream Products

• 910330-28-8 5-(m-trifluoromethylphenyl)-2-tetralone 
• 910330-48-2 8-(m-trifluoromethylphenyl)-1,2-dihydronaphthalene 
• 910330-45-9 5-(m-trifluoromethylphenyl)-1-tetralol 

Relevant academic research and scientific papers

THERAPEUTIC AGENTS

The invention provides well-defined compounds that are either EP2 agonists, EP4 agonists, or mixed EP2/EP4 agonist. The compounds are useful for treating a variety of pathological conditions associated with acti

Novel ligands for the human histamine H1 receptor: Synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes

This paper reports the synthesis of a novel series of (±)-2-dimethylamino- 5- and 6-phenyl-1,2,3,4-tetrahydronaphthalene derivatives (5- and 6-APTs), and, corresponding affinity, functional activity, and, molecular modeling studies with regard to drug des